Procalcitonin is an option included in our sepsis order sets. However, I find 
it is not routinely ordered.

Christine Aceves, MSN, RN, CNL, CEN
Sepsis Program Manager
Nursing Quality
Stanford Health Care
300 Pasteur Dr., HG021A  MC 5221 Stanford, CA 94305
O: 650.498.0971   C: 650.483.2248  P: 650.723.8222 ID# 26611
[email protected]


Confidential Information: This communication and any attachments may contain 
confidential or privileged information for the use by the designated 
recipient(s) named above. If you are not the intended recipient, you are hereby 
notified that you have received this communication in error and that any 
review, disclosure, dissemination, distribution or copying of it or the 
attachments is strictly prohibited. If you have received this communication in 
error, please contact me and destroy all copies of the communication and 
attachments. Thank you.

-----Original Message-----
From: Sepsisgroups [mailto:[email protected]] On 
Behalf Of [email protected]
Sent: Tuesday, February 21, 2017 12:11 PM
To: [email protected]
Subject: Sepsisgroups Digest, Vol 235, Issue 7

Send Sepsisgroups mailing list submissions to
        [email protected]

To subscribe or unsubscribe via the World Wide Web, visit
        http://lists.sepsisgroups.org/listinfo.cgi/sepsisgroups-sepsisgroups.org

or, via email, send a message with subject or body 'help' to
        [email protected]

You can reach the person managing the list at
        [email protected]

When replying, please edit your Subject line so it is more specific than "Re: 
Contents of Sepsisgroups digest..."


Today's Topics:

   1. Sepsis-3, 2016 Guidelines, and CMS (Seckel, Maureen M)
   2. Re: Procalcitonin (Humiston, Patricia)


----------------------------------------------------------------------

Message: 1
Date: Mon, 20 Feb 2017 19:49:21 +0000
From: "Seckel, Maureen M" <[email protected]>
To: "[email protected]"
        <[email protected]>
Subject: [Sepsis Groups] Sepsis-3, 2016 Guidelines, and CMS
Message-ID: <[email protected]>
Content-Type: text/plain; charset="us-ascii"

Hi,

Has anyone heard of any timeframe for discussion with CMS about reviewing the 
current Sep-1 performance measures since the publication of Sepsis-3 
definitions and the 2016 Surviving Sepsis Guidelines?  Will there be a 
discussion?

Maureen A. Seckel, APRN, ACNS-BC, CCNS, CCRN, FCCM Lead CNS Medical Pulmonary 
Critical Care Sepsis Coordinator Christiana Care Health System
4755 Ogletown-Stanton Road
3E29
Newark, DE 19718
Office 302 733-6023
[email protected]


-------------- next part --------------
An HTML attachment was scrubbed...
URL: 
<http://lists.sepsisgroups.org/pipermail/sepsisgroups-sepsisgroups.org/attachments/20170220/099e7364/attachment.html>

------------------------------

Message: 2
Date: Tue, 21 Feb 2017 11:56:56 -0500
From: "Humiston, Patricia" <[email protected]>
To: Gena Henriques <[email protected]>,
        "[email protected]"
        <[email protected]>
Subject: Re: [Sepsis Groups] Procalcitonin
Message-ID:
        <[email protected]>
Content-Type: text/plain; charset="utf-8"

No not as of this time, but there is ongoing discussions

Patricia Humiston, MBA RN-C
Division of Healthcare Quality
Baystate Health Systems
(413) 794-0194/beeper#40194
[email protected]<mailto:[email protected]>

From: Sepsisgroups [mailto:[email protected]] On 
Behalf Of Gena Henriques
Sent: Tuesday, February 21, 2017 9:23 AM
To: [email protected]
Subject: [Sepsis Groups] Procalcitonin

 Hi,

    Has anyone included procalcitonin on sepsis order sets?  If not, are your 
physicians ordering it routinely?


    Thanks,
    Gena Henriques, MSN, RN
    Sepsis Coordinator
    Touro Infirmary

----------------------------------------------------------------------
Please view our annual report at http://www.bhannualreport.org
 

CONFIDENTIALITY NOTICE: This e-mail communication and any attachments may 
contain confidential and privileged information for the use of the designated 
recipients named above. If you are not the intended recipient, you are hereby 
notified that you have received this communication in error and that any 
review, disclosure, dissemination, distribution or copying of it or its 
contents is prohibited. If you have received this communication in error, 
please reply to the sender immediately or by telephone at 413-794-0000 and 
destroy all copies of this communication and any attachments. For further 
information regarding Baystate Health's privacy policy, please visit our 
Internet site at https://www.baystatehealth.org.
-------------- next part --------------
An HTML attachment was scrubbed...
URL: 
<http://lists.sepsisgroups.org/pipermail/sepsisgroups-sepsisgroups.org/attachments/20170221/6733806c/attachment-0001.htm>

------------------------------

Subject: Digest Footer

_______________________________________________
Sepsisgroups mailing list
[email protected]
http://lists.sepsisgroups.org/listinfo.cgi/sepsisgroups-sepsisgroups.org


------------------------------

End of Sepsisgroups Digest, Vol 235, Issue 7
********************************************

_______________________________________________
Sepsisgroups mailing list
[email protected]
http://lists.sepsisgroups.org/listinfo.cgi/sepsisgroups-sepsisgroups.org

Reply via email to